Fig. 3
From: Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
Multivariate Cox proportional hazards regression analysis of all-cause death for cancer patients with COVID-19 treated with azvudine and Paxlovid.
